Evidence map›Paper›PMID 28790025›Full record

ArticleJMIR cancer2017

Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study.

Wim G Groen, Wilma Kuijpers, Hester Sa Oldenburg, Michel Wjm Wouters, Neil K Aaronson, Wim H van Harten

Abstract read
In one paragraph

Article in JMIR cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Interactive digital tools to support empowerment of people with cancer: a systematic literature review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Home-based rehabilitation in inoperable non-small cell lung cancer-the patient experience.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wim G GroenDivision of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0002-6300-5189
Wilma KuijpersDivision of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0002-5258-5923
Hester Sa OldenburgDivision of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0001-8626-1401
Michel Wjm WoutersDivision of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0001-6173-0662
Neil K AaronsonDivision of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0003-2574-4850
Wim H van HartenDivision of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0001-9580-0489

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyAVL is an interactive portal for cancer patients that aims to support lung cancer patients.

objectiveWe aimed to evaluate the feasibility and usability of the patient portal and generate preliminary evidence on its impact.

methodsLung cancer patients currently or recently treated with curative intent could use MyAVL noncommittally for 4 months. Feasibility, usability, and preliminary impact (ie, patient activation, quality of life, and physical activity) were studied by means of questionnaires, a focus group, and analysis of user log data.

resultsWe included 37 of 123 eligible patients (mean age 59.6 years). The majority of responses (82%) were positive about using MyAVL, 69% saw it as a valuable addition to care, and 56% perceived increased control over their health. No positive effects could be substantiated on the impact measures.

conclusionsMyAVL appears to be a feasible and user-friendly, multifunctional eHealth program for a selected group of lung cancer patients. However, it needs further improvements to positively impact patient outcomes.

Indexed as

eHealthfeasibilitynon-small cell lung cancerpatient empowermentpatient portalsupportive care

Identifiers

PMID28790025
PMCPMC5566630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.